Getinge AB
STO:GETI B

Watchlist Manager
Getinge AB Logo
Getinge AB
STO:GETI B
Watchlist
Price: 179.6 SEK 0.62% Market Closed
Market Cap: 48.9B SEK
Have any thoughts about
Getinge AB?
Write Note

Getinge AB
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Getinge AB
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Getinge AB
STO:GETI B
Operating Expenses
-kr10.3B
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Operating Expenses
-kr4.4B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Operating Expenses
-kr447.4m
CAGR 3-Years
-47%
CAGR 5-Years
-47%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Operating Expenses
-kr304.9m
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
-13%
Arjo AB (publ)
STO:ARJO B
Operating Expenses
-kr3.8B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Sedana Medical AB (publ)
STO:SEDANA
Operating Expenses
-kr176.2m
CAGR 3-Years
-14%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
No Stocks Found

Getinge AB
Glance View

Market Cap
48.9B SEK
Industry
Health Care

Getinge AB, rooted in the lush landscapes of Sweden, has steadily evolved into a global leader in the medical technology sector. The company began its journey by manufacturing traditional sterilizers over a century ago. Over time, Getinge has carefully navigated and adapted to the ever-changing dynamics of the healthcare industry, positioning itself squarely at the intersection of innovation and practicality. Today, Getinge specializes in a broad spectrum of medical equipment and systems, focusing on critical care, surgery, and infection prevention. This focus is intricately designed to cater to hospitals and healthcare facilities worldwide, ensuring that patients receive the highest standard of care during complex procedures and critical conditions. Revenue streams for Getinge are as diversified as its product portfolio, comprising equipment sales, service contracts, and consumables. The company’s product offerings range from sophisticated ventilators and state-of-the-art heart-lung machines, to efficient sterilization and surgical workflow products. Beyond simply selling devices, Getinge builds sustainable revenue through long-term service agreements and the sale of replacement parts and consumables, which are essential for the ongoing, optimal operation of its technologically advanced machinery. This strategic emphasis on combining cutting-edge product development with a robust support infrastructure underscores Getinge’s business model, ensuring loyalty and ongoing relationships with healthcare institutions globally.

GETI B Intrinsic Value
282.94 SEK
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Getinge AB's Operating Expenses?
Operating Expenses
-10.3B SEK

Based on the financial report for Dec 31, 2023, Getinge AB's Operating Expenses amounts to -10.3B SEK.

What is Getinge AB's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
2%

Over the last year, the Operating Expenses growth was -9%. The average annual Operating Expenses growth rates for Getinge AB have been -2% over the past three years , 2% over the past five years .

Back to Top